ProQR Therapeutics Correlations

PRQR Stock

USD 1.65 0.02 1.23%

The current 90-days correlation between ProQR Therapeutics and Annexon is -0.11 (i.e., Good diversification). The correlation of ProQR Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

ProQR Therapeutics Correlation With Market

Significant diversification

The correlation between ProQR Therapeutics BV and DJI is 0.04 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding ProQR Therapeutics BV and DJI in the same portfolio, assuming nothing else is changed.

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in ProQR Therapeutics BV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index.

Moving together with ProQR Stock

0.81	CDIOW	Cardio Diagnostics	Pair Corr
0.72	ELVN	Enliven Therapeutics	Pair Corr
0.75	ASMB	Assembly Biosciences Earnings Call This Week	Pair Corr
0.75	CDIO	Cardio Diagnostics	Pair Corr
0.73	CRNX	Crinetics Pharmaceuticals	Pair Corr
0.73	DIS	Walt Disney	Pair Corr
0.65	MSFT	Microsoft Aggressive Push	Pair Corr

Moving against ProQR Stock

0.57	GE	GE Aerospace	Pair Corr
0.55	WM	Waste Management	Pair Corr
0.5	LUCD	Lucid Diagnostics	Pair Corr
0.47	PLX	Protalix Biotherapeutics	Pair Corr
0.7	MMM	3M Company	Pair Corr
0.66	CVX	Chevron Corp	Pair Corr
0.64	JNJ	Johnson Johnson Sell-off Trend	Pair Corr
0.58	T	ATT Inc Sell-off Trend	Pair Corr
0.58	XOM	Exxon Mobil Corp Earnings Call Next Week	Pair Corr
0.37	IBM	International Business	Pair Corr

Related Correlations Analysis

	ANNX	ARWR	DAWN	TERN	ALNY	WVE	BPMC	APLS	ASMB	SPRO
ANNX		0.54	0.73	0.9	-0.19	0.88	0.11	0.9	0.9	0.9	ANNX
ARWR	0.54		0.85	0.68	0.22	0.68	0.45	0.73	0.66	0.53	ARWR
DAWN	0.73	0.85		0.74	0.22	0.75	0.45	0.83	0.77	0.64	DAWN
TERN	0.9	0.68	0.74		-0.21	0.94	0.03	0.94	0.83	0.9	TERN
ALNY	-0.19	0.22	0.22	-0.21		-0.14	0.8	-0.11	-0.13	-0.33	ALNY
WVE	0.88	0.68	0.75	0.94	-0.14		0.1	0.94	0.82	0.84	WVE
BPMC	0.11	0.45	0.45	0.03	0.8	0.1		0.15	0.19	-0.09	BPMC
APLS	0.9	0.73	0.83	0.94	-0.11	0.94	0.15		0.87	0.87	APLS
ASMB	0.9	0.66	0.77	0.83	-0.13	0.82	0.19	0.87		0.87	ASMB
SPRO	0.9	0.53	0.64	0.9	-0.33	0.84	-0.09	0.87	0.87		SPRO
	ANNX	ARWR	DAWN	TERN	ALNY	WVE	BPMC	APLS	ASMB	SPRO

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

WVE	+ 0.94	TERN
APLS	+ 0.94	TERN
APLS	+ 0.94	WVE
TERN	+ 0.9	ANNX
APLS	+ 0.9	ANNX
ASMB	+ 0.9	ANNX

High negative correlations

SPRO	- 0.33	ALNY
ALNY	- 0.21	TERN
ALNY	- 0.19	ANNX
WVE	- 0.14	ALNY
ASMB	- 0.13	ALNY
APLS	- 0.11	ALNY

Risk-Adjusted Indicators

There is a big difference between ProQR Stock performing well and ProQR Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze ProQR Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
ANNX	3.54	(0.73)	0.00	(0.62)	0.00	0.00	5.94	(8.53)	26.02
ARWR	2.71	(0.41)	0.00	(0.29)	0.00	0.00	4.71	(6.35)	19.61
DAWN	2.87	(0.52)	0.00	(0.64)	0.00	0.00	6.36	(6.67)	22.86
TERN	3.05	(0.92)	0.00	(1.16)	0.00	0.00	5.03	(6.98)	19.13
ALNY	1.94	0.32	0.15	0.22	1.88	(2.44)	4.69	(3.48)	15.40
WVE	3.00	(0.46)	0.00	1.47	0.00	0.00	7.43	(5.88)	19.40
BPMC	2.13	0.05	0.00	(0.03)	0.00	0.00	5.39	(4.23)	26.30
APLS	2.14	(0.37)	0.00	(0.43)	0.00	0.00	4.11	(4.33)	20.77
ASMB	3.04	(0.35)	0.00	(0.37)	0.00	0.00	6.63	(5.05)	24.82
SPRO	2.59	(0.31)	0.00	(0.73)	0.00	0.00	5.13	(6.25)	21.98

ProQR Therapeutics Corporate Management

Aniz MD	Chief Officer	Profile
Domenico Valerio	Founder Board	Profile
Sarah Kiely	Vice Communications	Profile
Rene Beukema	Chief Corporate Devel. Officer, General Counsel, Corporate Secretary and Member of Management Board	Profile
Sheila Sponselee	VP Operations	Profile
Gerard Platenburg	Chief Innovation Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC